168 related articles for article (PubMed ID: 38036520)
1. The mitochondrial NADH shuttle system is a targetable vulnerability for Group 3 medulloblastoma in a hypoxic microenvironment.
Contenti J; Guo Y; Mazzu A; Irondelle M; Rouleau M; Lago C; Leva G; Tiberi L; Ben-Sahra I; Bost F; Mazure NM
Cell Death Dis; 2023 Nov; 14(11):784. PubMed ID: 38036520
[TBL] [Abstract][Full Text] [Related]
2. Saturation of the mitochondrial NADH shuttles drives aerobic glycolysis in proliferating cells.
Wang Y; Stancliffe E; Fowle-Grider R; Wang R; Wang C; Schwaiger-Haber M; Shriver LP; Patti GJ
Mol Cell; 2022 Sep; 82(17):3270-3283.e9. PubMed ID: 35973426
[TBL] [Abstract][Full Text] [Related]
3. Suppression of the mitochondrial oxidation of (-)-palmitylcarnitine by the malate-aspartate and alpha-glycerophosphate shuttles.
Lumeng L; Bremer J; Davis EJ
J Biol Chem; 1976 Jan; 251(2):277-84. PubMed ID: 1245472
[TBL] [Abstract][Full Text] [Related]
4. The malate-aspartate shuttle is important for de novo serine biosynthesis.
Broeks MH; Meijer NWF; Westland D; Bosma M; Gerrits J; German HM; Ciapaite J; van Karnebeek CDM; Wanders RJA; Zwartkruis FJT; Verhoeven-Duif NM; Jans JJM
Cell Rep; 2023 Sep; 42(9):113043. PubMed ID: 37647199
[TBL] [Abstract][Full Text] [Related]
5. Inborn disorders of the malate aspartate shuttle.
Broeks MH; van Karnebeek CDM; Wanders RJA; Jans JJM; Verhoeven-Duif NM
J Inherit Metab Dis; 2021 Jul; 44(4):792-808. PubMed ID: 33990986
[TBL] [Abstract][Full Text] [Related]
6. Malate-aspartate shuttle, cytoplasmic NADH redox potential, and energetics in vascular smooth muscle.
Barron JT; Gu L; Parrillo JE
J Mol Cell Cardiol; 1998 Aug; 30(8):1571-9. PubMed ID: 9737943
[TBL] [Abstract][Full Text] [Related]
7. Malate-aspartate shuttle inhibitor aminooxyacetic acid leads to decreased intracellular ATP levels and altered cell cycle of C6 glioma cells by inhibiting glycolysis.
Wang C; Chen H; Zhang M; Zhang J; Wei X; Ying W
Cancer Lett; 2016 Aug; 378(1):1-7. PubMed ID: 27157912
[TBL] [Abstract][Full Text] [Related]
8. The malate-aspartate NADH shuttle components are novel metabolic longevity regulators required for calorie restriction-mediated life span extension in yeast.
Easlon E; Tsang F; Skinner C; Wang C; Lin SJ
Genes Dev; 2008 Apr; 22(7):931-44. PubMed ID: 18381895
[TBL] [Abstract][Full Text] [Related]
9. Oxidation of cytosolic NADH by the malate-aspartate shuttle in HuH13 human hepatoma cells.
Matsuno T
Int J Biochem; 1992 Feb; 24(2):313-5. PubMed ID: 1310290
[TBL] [Abstract][Full Text] [Related]
10. SIRT3-dependent GOT2 acetylation status affects the malate-aspartate NADH shuttle activity and pancreatic tumor growth.
Yang H; Zhou L; Shi Q; Zhao Y; Lin H; Zhang M; Zhao S; Yang Y; Ling ZQ; Guan KL; Xiong Y; Ye D
EMBO J; 2015 Apr; 34(8):1110-25. PubMed ID: 25755250
[TBL] [Abstract][Full Text] [Related]
11. The malate-aspartate shuttle (Borst cycle): How it started and developed into a major metabolic pathway.
Borst P
IUBMB Life; 2020 Nov; 72(11):2241-2259. PubMed ID: 32916028
[TBL] [Abstract][Full Text] [Related]
12. Neuronal and astrocytic shuttle mechanisms for cytosolic-mitochondrial transfer of reducing equivalents: current evidence and pharmacological tools.
McKenna MC; Waagepetersen HS; Schousboe A; Sonnewald U
Biochem Pharmacol; 2006 Feb; 71(4):399-407. PubMed ID: 16368075
[TBL] [Abstract][Full Text] [Related]
13. C/EBPβ-LIP mediated activation of the malate-aspartate shuttle sensitizes cells to glycolysis inhibition.
Ackermann T; Zuidhof HR; Müller C; Kortman G; Rutten MGS; Broekhuis MJC; Zaini MA; Hartleben G; Calkhoven CF
Mol Metab; 2023 Jun; 72():101726. PubMed ID: 37062524
[TBL] [Abstract][Full Text] [Related]
14. Fluctuations in Cytosolic Calcium Regulate the Neuronal Malate-Aspartate NADH Shuttle: Implications for Neuronal Energy Metabolism.
Satrústegui J; Bak LK
Neurochem Res; 2015 Dec; 40(12):2425-30. PubMed ID: 26138554
[TBL] [Abstract][Full Text] [Related]
15. Malate-Aspartate Shuttle Inhibitor Aminooxyacetate Acid Induces Apoptosis and Impairs Energy Metabolism of Both Resting Microglia and LPS-Activated Microglia.
Chen H; Wang C; Wei X; Ding X; Ying W
Neurochem Res; 2015 Jun; 40(6):1311-8. PubMed ID: 25998884
[TBL] [Abstract][Full Text] [Related]
16. Magnitude of malate-aspartate reduced nicotinamide adenine dinucleotide shuttle activity in intact respiring tumor cells.
Greenhouse WV; Lehninger AL
Cancer Res; 1977 Nov; 37(11):4173-81. PubMed ID: 198130
[TBL] [Abstract][Full Text] [Related]
17. Regulation of lactate production at the onset of ischaemia is independent of mitochondrial NADH/NAD+: insights from in silico studies.
Zhou L; Stanley WC; Saidel GM; Yu X; Cabrera ME
J Physiol; 2005 Dec; 569(Pt 3):925-37. PubMed ID: 16223766
[TBL] [Abstract][Full Text] [Related]
18. MDH1 deficiency is a metabolic disorder of the malate-aspartate shuttle associated with early onset severe encephalopathy.
Broeks MH; Shamseldin HE; Alhashem A; Hashem M; Abdulwahab F; Alshedi T; Alobaid I; Zwartkruis F; Westland D; Fuchs S; Verhoeven-Duif NM; Jans JJM; Alkuraya FS
Hum Genet; 2019 Dec; 138(11-12):1247-1257. PubMed ID: 31538237
[TBL] [Abstract][Full Text] [Related]
19. Oxidation of cytosolic NADH by the malate-aspartate shuttle in MC29 hepatoma cells.
Matsuno T
Cell Biol Int Rep; 1989 Sep; 13(9):739-45. PubMed ID: 2805084
[TBL] [Abstract][Full Text] [Related]
20. Octanoate affects 2,4-dinitrophenol uncoupling in intact isolated rat hepatocytes.
Sibille B; Keriel C; Fontaine E; Catelloni F; Rigoulet M; Leverve XM
Eur J Biochem; 1995 Jul; 231(2):498-502. PubMed ID: 7635161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
